+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID06771193

RETRACE Study on Disease and Treatment Patterns in High-Risk Locally Advanced or RecurrentMetastatic Cervical Cancer in Italy

Led by MSD Italia S.r.l. · Updated on 2025-07-20

200

Participants Needed

11

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a multicenter observational and retrospective study to describe the characteristics of patients and their disease, as well as treatment patterns, for locally advanced, recurrent, or metastatic cervical cancer in Italy. The study includes patients diagnosed between January 2018 and December 2021. It focuses on understanding disease stages, including large tumors confined to the cervix or nearby tissues, local tumor regrowth, and cancer spread beyond the pelvis. The study gathers data by reviewing medical records and physician notes from patients treated for advanced cervical cancer during the specified period. It categorizes patients into risk groups and examines differences in their treatment approaches. This study does not involve experimental treatments but analyzes past treatment patterns and outcomes. Participants medical charts will be reviewed to collect information such as treatment types, recurrence rates, survival after treatment, time from remission to recurrence, and resource use related to different treatments. Secondary data include screening program participation, HPV subtype presence, history of HPV-related lesions, and PD-L1 expression levels. The study is observational, with no active intervention, and relies on past medical data.

CONDITIONS

Brief Title

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

Research Team

S

Stefania Lopez

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here